Immatics Future Growth
Future criteria checks 1/6
Immatics's earnings are forecast to decline at 8.1% per annum while its annual revenue is expected to grow at 13.2% per year. EPS is expected to grow by 0.6% per annum.
Key information
-8.1%
Earnings growth rate
0.6%
EPS growth rate
Biotechs earnings growth | 31.2% |
Revenue growth rate | 13.2% |
Future return on equity | n/a |
Analyst coverage | Good |
Last updated | 31 May 2024 |
Recent future growth updates
Recent updates
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2026 | 49 | -164 | -162 | N/A | 4 |
12/31/2025 | 58 | -131 | -137 | N/A | 6 |
12/31/2024 | 67 | -105 | -116 | N/A | 7 |
3/31/2024 | 74 | -80 | -26 | 9 | N/A |
12/31/2023 | 54 | -97 | -13 | 18 | N/A |
9/30/2023 | 76 | -84 | -117 | -92 | N/A |
6/30/2023 | 85 | -79 | -105 | -86 | N/A |
3/31/2023 | 80 | -68 | -40 | -31 | N/A |
12/31/2022 | 173 | 38 | 94 | 100 | N/A |
9/30/2022 | 151 | 34 | 97 | 102 | N/A |
6/30/2022 | 142 | 28 | 113 | 119 | N/A |
3/31/2022 | 130 | 15 | 38 | 44 | N/A |
12/31/2021 | 35 | -93 | -90 | -85 | N/A |
9/30/2021 | 28 | -95 | -86 | -81 | N/A |
6/30/2021 | 30 | -231 | -133 | -127 | N/A |
3/31/2021 | 32 | -226 | -97 | -91 | N/A |
12/31/2020 | 31 | -211 | -88 | -81 | N/A |
9/30/2020 | 26 | -208 | -38 | -31 | N/A |
6/30/2020 | 23 | -49 | 75 | 81 | N/A |
3/31/2020 | 22 | -34 | 55 | 60 | N/A |
12/31/2019 | 18 | -32 | 69 | 71 | N/A |
12/31/2018 | 4 | -31 | 20 | 21 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 4A3 is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: 4A3 is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: 4A3 is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: 4A3's revenue (13.2% per year) is forecast to grow faster than the German market (5.2% per year).
High Growth Revenue: 4A3's revenue (13.2% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if 4A3's Return on Equity is forecast to be high in 3 years time